Sonoma Pharmaceuticals, Inc. (SNOA)
NASDAQ: SNOA · Real-Time Price · USD
2.910
-0.020 (-0.68%)
At close: Feb 27, 2026, 4:00 PM EST
2.790
-0.120 (-4.12%)
After-hours: Feb 27, 2026, 7:50 PM EST
Sonoma Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Revenue | 17.72 | 14.29 | 12.74 | 13.27 | 12.63 | 18.63 | Upgrade
|
| Revenue Growth (YoY) | 26.83% | 12.20% | -4.05% | 5.10% | -32.21% | 3.91% | Upgrade
|
| Cost of Revenue | 10.96 | 8.82 | 7.99 | 8.8 | 8.64 | 12.07 | Upgrade
|
| Gross Profit | 6.76 | 5.47 | 4.75 | 4.48 | 3.99 | 6.56 | Upgrade
|
| Selling, General & Admin | 7.39 | 7.36 | 7.58 | 8.84 | 9.76 | 9.45 | Upgrade
|
| Research & Development | 2.14 | 1.81 | 1.87 | 0.21 | 0.13 | 0.56 | Upgrade
|
| Operating Expenses | 9.53 | 9.18 | 9.45 | 9.05 | 9.88 | 10.01 | Upgrade
|
| Operating Income | -2.77 | -3.71 | -4.7 | -4.57 | -5.89 | -3.45 | Upgrade
|
| Interest Expense | - | - | - | - | -0.01 | - | Upgrade
|
| Interest & Investment Income | - | - | - | - | - | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.24 | 0.24 | -0.83 | -0.69 | -0.58 | -0.69 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.93 | 0.56 | 0.5 | 0.08 | 0.19 | 0.1 | Upgrade
|
| EBT Excluding Unusual Items | -3.45 | -2.91 | -5.03 | -5.18 | -6.29 | -4.04 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | 0.15 | 0.14 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.72 | - | Upgrade
|
| Pretax Income | -3.45 | -2.91 | -5.03 | -5.18 | -5.42 | -3.9 | Upgrade
|
| Income Tax Expense | -0.08 | 0.55 | -0.2 | -0.03 | -0.33 | 0.71 | Upgrade
|
| Earnings From Continuing Operations | -3.37 | -3.46 | -4.84 | -5.15 | -5.09 | -4.62 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | - | 0.67 | Upgrade
|
| Net Income | -3.37 | -3.46 | -4.84 | -5.15 | -5.09 | -3.95 | Upgrade
|
| Net Income to Common | -3.37 | -3.46 | -4.84 | -5.15 | -5.09 | -3.95 | Upgrade
|
| Shares Outstanding (Basic) | 2 | 1 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 2 | 1 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 60.61% | 172.75% | 168.12% | 27.93% | 32.92% | 35.14% | Upgrade
|
| EPS (Basic) | -2.04 | -2.79 | -10.63 | -30.35 | -38.34 | -39.58 | Upgrade
|
| EPS (Diluted) | -2.04 | -2.79 | -10.63 | -30.35 | -38.34 | -39.58 | Upgrade
|
| Free Cash Flow | -3.72 | -0.17 | -2.4 | -6.42 | -4.39 | -3.56 | Upgrade
|
| Free Cash Flow Per Share | -2.25 | -0.14 | -5.28 | -37.84 | -33.06 | -35.64 | Upgrade
|
| Gross Margin | 38.16% | 38.25% | 37.26% | 33.73% | 31.62% | 35.21% | Upgrade
|
| Operating Margin | -15.61% | -25.97% | -36.91% | -34.43% | -46.62% | -18.51% | Upgrade
|
| Profit Margin | -19.02% | -24.20% | -37.97% | -38.81% | -40.28% | -21.20% | Upgrade
|
| Free Cash Flow Margin | -20.98% | -1.18% | -18.85% | -48.38% | -34.72% | -19.09% | Upgrade
|
| EBITDA | -2.63 | -3.57 | -4.53 | -4.45 | -5.7 | -3.22 | Upgrade
|
| EBITDA Margin | -14.84% | -25.00% | -35.53% | -33.49% | -45.15% | -17.30% | Upgrade
|
| D&A For EBITDA | 0.14 | 0.14 | 0.18 | 0.13 | 0.19 | 0.23 | Upgrade
|
| EBIT | -2.77 | -3.71 | -4.7 | -4.57 | -5.89 | -3.45 | Upgrade
|
| EBIT Margin | -15.61% | -25.97% | -36.91% | -34.43% | -46.62% | -18.51% | Upgrade
|
| Advertising Expenses | - | 0.19 | 0.16 | 0.16 | 0.09 | 0.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.